IMUX
IMUX
NASDAQ · Biotechnology

Immunic Inc

$0.62
+0.03 (+5.26%)
As of Feb 8, 2:15 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.96M 11.88M 13.51M
Net Income 575.0K 486.8K 473.9K
EPS
Profit Margin 4.4% 4.1% 3.5%
Rev Growth -0.8% +15.7% +3.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 20.71M 27.29M 27.63M
Total Equity 29.20M 26.96M 32.05M
D/E Ratio 0.71 1.01 0.86
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 905.5K 814.6K 969.2K
Free Cash Flow 454.1K 555.8K 696.0K